Effectiveness and safety of bulevirtide monotherapy 2 mg/die in hdv patients with compensated cirrhosis and clinically significant portal hypertension
Title:
Effectiveness and safety of bulevirtide monotherapy 2 mg/die in hdv patients with compensated cirrhosis and clinically significant portal hypertension
Author:
Degasperi, E. Loglio, A. Uceda Renteria, S.C. Sambarino, D. Borghi, M. Perbellini, R. Scholtes, C. Facchetti, F. Fraquelli, M. Costantino, A. Orsini, C. Ceriotti, F. Zoulim, F. Lampertico, P.